The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Genetic, Clinical, and Radiographic Delineation of Hallervorden–Spatz Syndrome
Open accessAbstract
BACKGROUND: Hallervorden-Spatz syndrome is an autosomal recessive disorder characterized by dystonia, parkinsonism, and iron accumulation in the brain. Many patients with this disease have mutations in the gene encoding pantothenate kinase 2 (PANK2); these patients are said to have pantothenate kinase-associated neurodegeneration. In this study, we compared the clinical and radiographic features of patients with Hallervorden-Spatz syndrome with and without mutations in PANK2. METHODS: One hundred twenty-three patients from 98 families with a diagnosis of Hallervorden-Spatz syndrome were classified on the basis of clinical assessment as having classic disease (characterized by early onset with rapid progression) or atypical disease (later onset with slow progression). Their genomic DNA was sequenced for PANK2 mutations. RESULTS: All patients with classic Hallervorden-Spatz syndrome and one third of those with atypical disease had PANK2 mutations. Whereas almost all mutations in patients with atypical disease led to amino acid changes, those in patients with classic disease more often resulted in predicted protein truncation. Patients with atypical disease who had PANK2 mutations were more likely to have prominent speech-related and psychiatric symptoms than patients with classic disease or mutation-negative patients with atypical disease. In all patients with pantothenate kinase-associated neurodegeneration, whether classic or atypical, T2-weighted magnetic resonance imaging (MRI) of the brain showed a specific pattern of hyperintensity within the hypointense medial globus pallidus. This pattern was not seen in any patients without mutations. CONCLUSIONS: PANK2 mutations are associated with all cases of classic Hallervorden-Spatz syndrome and one third of cases of atypical disease. A specific MRI pattern distinguishes patients with PANK2 mutations. Predicted levels of pantothenate kinase 2 protein correlate with the severity of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., & Hayflick, S. J. (2001) · Nature Genetics · doi:10.1038/ng572 · Cited by 752
Self-citationCurtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Dooling, E. C., Schoene, W. C., & Richardson, E. P. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490310072012 · Cited by 269
Hallervorden, J., & Spatz, H. (1922) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02878455 · Cited by 253
Hallervorden‐spatz syndrome: Clinical and magnetic resonance imaging correlations
Sethi, K. D., Adams, R. J., Loring, D. W., & El Gammal, T. (1988) · Annals of Neurology · doi:10.1002/ana.410240519 · Cited by 198
Hallervorden-Spatz Syndrome and Brain Iron Metabolism
Swaiman, K. F. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530240091029 · Cited by 196
Gitlin, J. D. (1998) · Pediatric Research · doi:10.1203/00006450-199809000-00001 · Cited by 171
Late‐onset Hallervorden‐Spatz disease presenting as familial parkinsonism
Jankovic, J. J., Kirkpatrick, J. B., Blomquist, K. A., Langlais, P. J., & Bird, E. D. (1985) · Neurology · doi:10.1212/wnl.35.2.227 · Cited by 108
HARP syndrome is allelic with pantothenate kinase–associated neurodegeneration
Ching, K. H. L., Westaway, S. K., Gitschier, J. M., Higgins, J. J., & Hayflick, S. J. (2002) · Neurology · doi:10.1212/wnl.58.11.1673 · Cited by 106
Self-citationRacial hygiene, active euthanasia, and Julius Hallervorden
Shevell, M. I. (1992) · Neurology · doi:10.1212/wnl.42.11.2214 · Cited by 79
Cited by
LEONARDI, R., ZHANG, Y., ROCK, C., & JACKOWSKI, S. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.04.001 · Cited by 644
Iron Overload in Human Disease
Fleming, R. E., & Ponka, P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1004967 · Cited by 587
Copper and iron disorders of the brain
Madsen, E., & Gitlin, J. D. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094232 · Cited by 557
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron
Morgan, N. V., Westaway, S. K., Morton, J. E. V., Gregory, A., Gissen, P., Sonek, S., Cangul, H., Coryell, J., Canham, N., Nardocci, N., et al. (2006) · Nature Genetics · doi:10.1038/ng1826 · Cited by 533
Self-citationCharacterization of PLA2G6 as a locus for dystonia‐parkinsonism
Paisan‐Ruiz, C., Bhatia, K. P., Li, A., Hernandez, D., Davis, M., Wood, N. W., Hardy, J., Houlden, H., Singleton, A., & Schneider, S. A. (2009) · Annals of Neurology · doi:10.1002/ana.21415 · Cited by 480
Clinical and genetic delineation of neurodegeneration with brain iron accumulation
Gregory, A., Polster, B. J., & Hayflick, S. J. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061929 · Cited by 364
Self-citationDifferential Diagnosis for Bilateral Abnormalities of the Basal Ganglia and Thalamus
Hegde, A. N., Mohan, S., Lath, N., & Lim, C. C. T. (2011) · RadioGraphics · doi:10.1148/rg.311105041 · Cited by 351
High‐field magnetic resonance imaging of brain iron: birth of a biomarker?
Schenck, J. F., & Zimmerman, E. A. (2004) · NMR in Biomedicine · doi:10.1002/nbm.922 · Cited by 337
Iron supplementation in early childhood: health benefits and risks
Iannotti, L. L., Tielsch, J. M., Black, M. M., & Black, R. E. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.6.1261 · Cited by 321
Neurodegeneration with brain iron accumulation
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63233-3.00019-1 · Cited by 317
The genetics and neuropathology of Parkinson’s disease
Houlden, H., & Singleton, A. B. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1013-5 · Cited by 316
T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation
McNeill, A., Birchall, D., Hayflick, S. J., Gregory, A., Schenk, J. F., Zimmerman, E. A., Shang, H., Miyajima, H., & Chinnery, P. F. (2008) · Neurology · doi:10.1212/01.wnl.0000310985.40011.d6 · Cited by 302
Self-citationAge-related Iron Deposition in the Basal Ganglia: Quantitative Analysis in Healthy Subjects
Aquino, D., Bizzi, A., Grisoli, M., Garavaglia, B., Bruzzone, M. G., Nardocci, N., Savoiardo, M., & Chiapparini, L. (2009) · Radiology · doi:10.1148/radiol.2522081399 · Cited by 296
Clinical whole exome sequencing in child neurology practice
Srivastava, S., Cohen, J. S., Vernon, H., Barañano, K., McClellan, R., Jamal, L., Naidu, S., & Fatemi, A. (2014) · Annals of Neurology · doi:10.1002/ana.24251 · Cited by 276
Individual dopaminergic neurons show raised iron levels in Parkinson disease
Oakley, A. E., Collingwood, J. F., Dobson, J., Love, G., Perrott, H. R., Edwardson, J. A., Elstner, M., & Morris, C. M. (2007) · Neurology · doi:10.1212/01.wnl.0000262033.01945.9a · Cited by 273
Neurodegeneration associated with genetic defects in phospholipase A 2
Gregory, A., Westaway, S. K., Holm, I. E., Kotzbauer, P. T., Hogarth, P., Sonek, S., Coryell, J. C., Nguyen, T. M., Nardocci, N., Zorzi, G., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000327094.67726.28 · Cited by 270
Self-citationClinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation
Chinnery, P. F., Crompton, D. E., Birchall, D., Jackson, M. J., Coulthard, A., Lombes, A., Quinn, N., Wills, A., Fletcher, N., Mottershead, J. P., et al. (2006) · Brain · doi:10.1093/brain/awl319 · Cited by 205
Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms
Levi, S., & Finazzi, D. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00099 · Cited by 164
An updated review of Parkinson's disease genetics and clinicopathological correlations
Ferreira, M., & Massano, J. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12616 · Cited by 167
Genetics of neurodegeneration with brain iron accumulation
Gregory, A., & Hayflick, S. J. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0181-3 · Cited by 104
Self-citationLamari, F., Mochel, F., Sedel, F., & Saudubray, J. M. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9509-7 · Cited by 104
Neuroferritinopathy: a new inborn error of iron metabolism
Keogh, M. J., Jonas, P., Coulthard, A., Chinnery, P. F., & Burn, J. (2012) · Neurogenetics · doi:10.1007/s10048-011-0310-9 · Cited by 49
Discordant expression of miR-103/7 and pantothenate kinase host genes in mouse
Polster, B. J., Westaway, S. K., Nguyen, T. M., Yoon, M. Y., & Hayflick, S. J. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.07.016 · Cited by 35
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Abbreviations miRNA microRNA PANK pantothenate kinase PKAN pantothenate kinase-associated neurodegeneration precursor microRNA pre-miRNA UTRs untranslated regions REFERENCES [1].”
BackgroundSelf-citationA review of psychiatric co-morbidity described in genetic and immune mediated movement disorders
Peall, K. J., Lorentzos, M. S., Heyman, I., Tijssen, M. A. J., Owen, M. J., Dale, R. C., & Kurian, M. A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.014 · Cited by 14
“05).[54] PLA2G6-associated neuro-degeneration (PLAN) describes three over-lapping disorders; classic infantile neuroaxonal dystrophy (INAD), atypical neuroaxonal dystrophy (atypical NAD) and PLA2G6related dystonia-parkinsonism.”
Background
Metadata
- Authors
- Hayflick, S. J., Westaway, S. K., Levinson, B., Zhou, B., Johnson, M. A., Ching, K. H. L., & Gitschier, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-01-02
- Volume
- 348
- Issue
- 1
- Pages
- 33-40
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102239505
- Cited by
- 714
- References
- 15
- FWCI
- 22.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.